Swiss-Prot entry

ID   ESR2_RAT       STANDARD;      PRT;   530 AA.
AC   Q62986; O35784; O35785; O55015; O55016; O70195; Q9R185;
DT   15-JUL-1999 (Rel. 38, Created)
DT   15-JUL-1999 (Rel. 38, Last sequence update)
DT   01-MAY-2005 (Rel. 47, Last annotation update)
DE   Estrogen receptor beta (ER-beta).
GN   Name=Esr2; Synonyms=Erbeta, Nr3a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; 
OC   Muridae; Murinae; Rattus. 
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE OF 46-530 (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Prostate;
RX   MEDLINE=96234066; PubMed=8650195 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1073/pnas.93.12.5925;
RA   Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S.,
RA   Gustafsson J.-A.;
RT   "Cloning of a novel receptor expressed in rat prostate and ovary.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5925-5930(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE OF 46-530 (ISOFORM 2).
RC   STRAIN=Wistar; TISSUE=Ovary;
RX   MEDLINE=98262932; PubMed=9600083 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1006/bbrc.1998.8590;
RA   Maruyama K., Endoh H., Sasaki-Iwaoka H., Kanou H., Shimaya E.,
RA   Hashimoto S., Kato S., Kawashima H.;
RT   "A novel isoform of rat estrogen receptor beta with 18 amino acid
RT   insertion in the ligand binding domain as a putative dominant negative
RT   regular of estrogen action.";
RL   Biochem. Biophys. Res. Commun. 246:142-147(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RC   STRAIN=Wistar; TISSUE=Prostate;
RA   Aldridge T.C.;
RT   "Tissue specific responses to estrogen: an explanation based on
RT   differential activation of multiple estrogen receptors with different
RT   estrogen response elements.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 46-530 (ISOFORMS 1; 3 AND 4).
RC   STRAIN=Sprague-Dawley;
RX   MEDLINE=98151005; PubMed=9492041 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1210/en.139.3.1082;
RA   Petersen D.N., Tkalcevic G.T., Koza-Taylor P.H., Turi T.G.,
RA   Brown T.A.;
RT   "Identification of estrogen receptor beta2, a functional variant of
RT   estrogen receptor beta expressed in normal rat tissues.";
RL   Endocrinology 139:1082-1092(1998).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 5).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Price R., Handa R.J.;
RT   "A novel splice variant of estrogen receptor beta found in rat
RT   brain.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH UBE1C.
RX   PubMed=11818503 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1210/me.16.2.315;
RA   Fan M., Long X., Bailey J.A., Reed C.A., Osborne E., Gize E.A.,
RA   Kirk E.A., Bigsby R.M., Nephew K.P.;
RT   "The activating enzyme of NEDD8 inhibits steroid receptor function.";
RL   Mol. Endocrinol. 16:315-330(2002).
CC   -!- FUNCTION: Binds estrogens with an affinity similar to that of ER-
CC       alpha, and activates expression of reporter genes containing
CC       estrogen response elements (ERE) in an estrogen-dependent manner.
CC       Isoform 3 and isoform 4 are unable to bind DNA and activate
CC       transcription due to the truncation of the DNA binding domain.
CC       Isoform 2 shows loss of ligand binding affinity and suppresses ER-
CC       alpha and ER-beta1 mediated transcriptional activation and may act
CC       as a dominant negative regulator of estrogen action.
CC   -!- SUBUNIT: Binds DNA as a homodimer. Can form a heterodimer with
CC       ESR1. Can also form heterodimers between isoform 1 and isoform 2.
CC       Interacts with NCOA3, NCOA5 and NCOA6 coactivators, leading to a
CC       strong increase of transcription of target genes (By similarity).
CC       Binds UBE1C.
CC   -!- SUBCELLULAR LOCATION: Nuclear.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist;
CC       Name=1; Synonyms=Beta1;
CC         IsoId=Q62986-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta2;
CC         IsoId=Q62986-2; Sequence=VSP_003699;
CC       Name=3; Synonyms=Beta1-delta3;
CC         IsoId=Q62986-3; Sequence=VSP_003697;
CC       Name=4; Synonyms=Beta2-delta3;
CC         IsoId=Q62986-4; Sequence=VSP_003697, VSP_003699;
CC       Name=5; Synonyms=Beta1-delta4;
CC         IsoId=Q62986-5; Sequence=VSP_003698;
CC   -!- TISSUE SPECIFICITY: Expressed in prostate, ovary, lung, liver,
CC       kidney, fat, bone, brain, uterus and testis.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain,
CC       a DNA-binding domain and a C-terminal steroid-binding domain.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily.
CC   -!- SIMILARITY: Contains 1 nuclear receptor DNA-binding domain.
CC   --------------------------------------------------------------------------
CC   This Swiss-Prot entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use as long as its content is in no way modified and this statement is not
CC   removed.
CC   --------------------------------------------------------------------------
DR   EMBL; U57439; AAC52602.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AB012721; BAA25431.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AJ002602; CAA05631.1; ALT_INIT. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AJ002603; CAA05632.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AF042058; AAB97424.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AF042059; AAB97425.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AF042060; AAB97426.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AF042061; AAB97427.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AF161187; AAD47637.1; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   PDB; 1HJ1; X-ray; A=255-509. [ExPASy / RCSB]
DR   PDB; 1QKN; X-ray; A=255-509. [ExPASy / RCSB]
DR   SMR; Q62986; 144-216.
DR   Ensembl; ENSRNOG00000005343; Rattus_norvegicus
DR   RGD; 2582; Esr2.
DR   GO; GO:0005634; C:nucleus; ISS.
DR   GO; GO:0030284; F:estrogen receptor activity; TAS.
DR   GO; GO:0004879; F:ligand-dependent nuclear receptor activity; ISS.
DR   GO; GO:0048019; F:receptor antagonist activity; ISS.
DR   GO; GO:0005496; F:steroid binding; ISS.
DR   GO; GO:0030528; F:transcription regulator activity; TAS.
DR   GO; GO:0030520; P:estrogen receptor signaling pathway; TAS.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISS.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; ISS.
DR   InterPro; IPR000536; Hrmon_recept_lig.
DR   InterPro; IPR001723; Stdhrmn_receptor.
DR   InterPro; IPR008946; Str_ncl_receptor.
DR   InterPro; IPR000324; VitD_receptor.
DR   InterPro; IPR001628; Znf_C4steroid.
DR   InterPro; Graphical view of domain structure.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   Pfam; Graphical view of domain structure.
DR   PIRSF; PIRSF002527; ER-ab; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   PRINTS; PR00350; VITAMINDR.
DR   ProDom; PD000035; Znf_C4steroid; 1.
DR   ProDom [Domain structure / List of seq. sharing at least 1 domain ]
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
DR   CMR; Q62986.
DR   HOVERGEN [Family / Alignment / Tree]
DR   BLOCKS; Q62986.
DR   ProtoNet; Q62986.
DR   ProtoMap; Q62986.
DR   PRESAGE; Q62986.
DR   DIP; Q62986.
DR   ModBase; Q62986.
DR   SWISS-2DPAGE; GET REGION ON 2D PAGE.
KW   3D-structure; Alternative splicing; DNA-binding; Nuclear protein;
KW   Phosphorylation; Receptor; Steroid-binding; Transcription;
KW   Transcription regulation; Zinc-finger.
FT   DOMAIN        1    148       Modulating.
FT   DNA_BIND    149    214       Nuclear receptor-type.
FT   ZN_FING     149    169       C4-type.
FT   ZN_FING     185    209       C4-type.
FT   DOMAIN      215    530       Steroid-binding.
FT   MOD_RES      87     87       Phosphoserine (By similarity).
FT   MOD_RES     488    488       Phosphotyrosine (By similarity).
FT   VARSPLIC    179    217       Missing (in isoform 3 and isoform 4).
FT                                /FTId=VSP_003697.
FT   VARSPLIC    219    318       Missing (in isoform 5).
FT                                /FTId=VSP_003698.
FT   VARSPLIC    364    364       R -> RSSEDPHWHVAQMKSAAPR (in isoform 2
FT                                and isoform 4).
FT                                /FTId=VSP_003699.
FT   CONFLICT     72     72       L -> Q (in Ref. 3 and 4).
FT   CONFLICT    150    150       P -> A (in Ref. 3 and 4).
FT   CONFLICT    165    165       S -> P (in Ref. 3; CAA05631).
FT   CONFLICT    505    505       S -> P (in Ref. 3; CAA05631).
FT   HELIX       265    275       
FT   STRAND      283    283       
FT   HELIX       291    315       
FT   TURN        317    318       
FT   HELIX       319    321       
FT   HELIX       324    347       
FT   TURN        348    349       
FT   TURN        351    352       
FT   STRAND      353    357       
FT   TURN        358    358       
FT   STRAND      359    363       
FT   HELIX       364    368       
FT   TURN        371    372       
FT   HELIX       374    389       
FT   TURN        390    391       
FT   HELIX       394    406       
FT   TURN        407    407       
FT   HELIX       416    442       
FT   TURN        443    444       
FT   HELIX       448    477       
FT   TURN        478    478       
SQ   SEQUENCE   530 AA;  59152 MW;  36F269D9FD773DA9 CRC64;
     MEIKNSPSSL SSPASYNCSQ SILPLEHGPI YIPSSYVDNR HEYSAMTFYS PAVMNYSVPG
     STSNLDGGPV RLSTSPNVLW PTSGHLSPLA THCQSSLLYA EPQKSPWCEA RSLEHTLPVN
     RETLKRKLSG SSCASPVTSP NAKRDAHFCP VCSDYASGYH YGVWSCEGCK AFFKRSIQGH
     NDYICPATNQ CTIDKNRRKS CQACRLRKCY EVGMVKCGSR RERCGYRIVR RQRSSSEQVH
     CLSKAKRNGG HAPRVKELLL STLSPEQLVL TLLEAEPPNV LVSRPSMPFT EASMMMSLTK
     LADKELVHMI GWAKKIPGFV ELSLLDQVRL LESCWMEVLM VGLMWRSIDH PGKLIFAPDL
     VLDRDEGKCV EGILEIFDML LATTSRFREL KLQHKEYLCV KAMILLNSSM YPLASANQEA
     ESSRKLTHLL NAVTDALVWV IAKSGISSQQ QSVRLANLLM LLSHVRHISN KGMEHLLSMK
     CKNVVPVYDL LLEMLNAHTL RGYKSSISGS ECSSTEDSKN KESSQNLQSQ
//